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Abstract 52 
The aim of this study was to elucidate the relationship between the urinary metabolic fingerprint and 53 
the effects of cocoa and cocoa fibre on body weight, hormone metabolism, intestinal immunity and 54 
microbiota composition. To this effect, Wistar rats were fed, for 3-weeks, a diet containing 10% cocoa 55 
(C10), or two other diets with same proportion of fibres: one based on cocoa fibre (CF) and another 56 
containing inulin as a reference diet (REF). Twenty-four hour urine samples were analysed by an 57 
untargeted 1H NMR spectroscopy-based metabonomic approach. Concentration of faecal IgA and 58 
plasma metabolic hormones were also quantified. The C10 diet decreased the intestinal IgA, plasma 59 
GLP-1 and glucagon concentrations and increased ghrelin levels compared to the REF group. Clear 60 
differences were observed between the metabolic profiles from the C10 group and those from the CF 61 
group. Urine metabolites derived from cocoa correlated with the cocoa effects on body weight, 62 
immunity and the gut microbiota. Overall, cocoa intake alters the host and bacterial metabolism 63 
concerning energy and amino acid pathways leading to a metabolic signature that can be used as a 64 
marker for consumption. This metabolic profile correlates with body weight, metabolic hormones, 65 
intestinal immunity and microbiota composition. 66 
 67 
 68 
69 
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Introduction 70 
Cocoa is considered a great source of bioactive compounds such as polyphenols and dietary fibre (DF), 71 
which have been attributed consistent positive health effects(1–5). Cocoa contains monomeric flavonoids 72 
such as the flavanols (–)-catechin , (+)-catechin and (–)-epicatechin, and mainly its oligomers and 73 
polymers known as procyanidins. These polymeric compounds are able to pass intact through the small 74 
intestine and to reach the colon(6), where they are metabolized by the intestinal microbiota. This 75 
conversion is crucial for their absorption and also for the generation of new compounds with greater 76 
bioactivity than their precursors(6–8). Thus, there is a growing body of evidence on the reciprocal 77 
relationship between bacteria and polyphenols that may help understand the documented benefits of 78 
polyphenols consumption(9). In fact, it has been extensively reported that both dietary polyphenols, 79 
including those from cocoa, and the corresponding microbially-derived phenolic metabolites modulate 80 
the gut microbiota composition in in vitro, in vivo and clinical studies(8,10–13). 81 
Similar ability to modulate the gut microbiota composition has been attributed to the DF, which has 82 
been described to  modulate short chain fatty acids (SCFA) production(14–18). Recently, cocoa fibre-83 
enriched intake in rats has been associated with the modulation of the gut microbiota and SCFA 84 
production(17). The DF fraction in cocoa is mainly rich in cellulose, followed by highly fermented 85 
pectic substances and hemicellulose, which is less fermentable than the former(19). After microbial 86 
transformation, the cocoa metabolites either from flavonoids or cocoa fibre (i.e. SCFA) are absorbed 87 
into the bloodstream(20,21). The microbial metabolites from flavanols, are mainly metabolized by liver 88 
phase-II enzymes to conjugated derivatives that are subsequently eliminated in urine(7). 89 
Previous preclinical studies carried out in our laboratory have evidenced that cocoa, cocoa flavanols 90 
and cocoa fibre modify some aspects of the intestinal and systemic immune response(2,13,17,22). On the 91 
other hand, a diet based on whole cocoa, but not based exclusively on its flavonoids or fibre, is able to 92 
reduce the body weight gain(13,17,23). Given that this effect on weight is not associated with a lower 93 
chow intake, it is necessary to further understand the mechanism involved in such effect. In this sense, 94 
an untargeted metabonomic approach is particularly useful, since aims to determine the broadest range 95 
of metabolites present in a biological samples without a priori information. Thus, due to it exploratory 96 
nature, this hypothesis-generating approach provides an unbiased screening of the metabolites and can 97 
detect alterations in biological pathways to provide insight into molecular mechanism. Therefore, the 98 
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objective of this study was to correlate the urinary metabolic variation associated with cocoa intake 99 
identified by 1H nuclear magnetic resonance (NMR) spectroscopy with the effects of cocoa on body 100 
weight, hormone metabolism, intestinal immunity and microbiota composition. Moreover, very limited 101 
data is available about the metabolic profile after cocoa fibre intake and even less the contribution of 102 
cocoa fibre to the above described effects ascribed to cocoa, thus it was also aimed in this study 103 
Materials and methods 104 
Animals and diets 105 
Female Wistar rats (3-week-old) were obtained from Janvier (Saint-Berthevin, France) and housed in 106 
pairs under conditions of controlled temperature and humidity in a 12:12 light-dark cycle. The rats 107 
were randomly distributed into three dietary groups: cocoa (C10), cocoa fibre (CF) and reference 108 
(REF) groups (n=10/each). The C10 group received chow containing 10% cocoa that provided a final 109 
diet concentration of 0.4% of polyphenols, 0.85% soluble fibre and 2.55% of insoluble fibre; the CF 110 
group received a diet with the same cocoa soluble and insoluble fibre proportions as the C10 group but 111 
with a very low amount of polyphenols (<0.02%); and the REF group received the same amount of 112 
fibre as the C10 group, being the soluble portion (0.85%) as inulin in order to distinguish the particular 113 
effect of cocoa fibre, as has been previously reported(24). Natural Forastero cocoa and cocoa fibre 114 
powders (provided by Idilia Foods S.L., formerly Nutrexpa S.L., Barcelona, Spain) with 4.02% and 115 
0.35% of polyphenols, respectively, were used to elaborate the C10 and CF diets. Inulin from chicory 116 
roots (Fibruline® Instant; InnovaFood 2005, S.L., Barcelona, Spain) was used as a reference soluble 117 
fibre. The three experimental diets were elaborated on basis of the AIN-93M formula by subtracting 118 
the amount of carbohydrates, proteins, lipids and insoluble fibre provided by the corresponding 119 
supplement. The three resulting diets were isoenergetic and had the same proportion of macronutrients 120 
(carbohydrates, proteins and lipids) and fibre as has been previously stated(24). Animals were given free 121 
access to water and food. The diets lasted for three weeks.  122 
Body weight and food intake were monitored throughout the study. Experiments were performed 123 
according to the Guide for the Care and Use of Laboratory Animals, and experimental procedures were 124 
approved by the Ethical Committee for Animal Experimentation of the University of Barcelona (ref. 125 
358/12). 126 
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Sample collection and processing 127 
The 24 h urine samples were collected, by means of metabolic cages, at 15 days after beginning the 128 
nutritional intervention. Centrifuged urines were kept at – 80 ºC until analysis. Moreover, blood 129 
samples were collected after three weeks and plasma was kept at - 80 ºC prior to metabolic hormones 130 
determination. Faecal samples were also collected at the third week of diet and the homogenates were 131 
obtained as previously described(17) and frozen at - 20 ºC until analysis. 132 
Sample preparation for 1H NMR analysis 133 
Urine samples were defrosted and prepared for 1H NMR spectroscopy by combining 400 µL of sample 134 
with 200 µL of phosphate buffer (pH 7.4; 100% D2O) containing 1 mM of 3-trimethylsilyl-1-[2,2,3,3-135 
2H4] propionate (TSP) as an external standard and 2 mM sodium azide as a bacteriocide. Samples were 136 
vortexed and particles were removed by centrifugation (13000 g for 10 min) prior to transferring 137 
550 µL to a 5 mm NMR tube. Standard one-dimensional 1H NMR spectra of the urine samples were 138 
acquired on a 500 MHz Bruker NMR spectrometer using a standard noesy experiment incorporating a 139 
pre-saturation pulse to attenuate the water signal. This experiment consisted of [recycle delay (RD)-140 
90○-t1-90○-tm-90○-acquire free induction decay]. The water signal was suppressed by irradiation during 141 
the RD of 2 s, with a mixing time (tm) of 10 µs. The acquisition time was set to 2.91 s and the 90○ pulse 142 
length was 15.87 µs. For each sample, 8 dummy scans were followed by 128 scans and collected in 143 
64K data points using a spectral width of 16 ppm. Prior to data analysis, NMR spectra were phased, 144 
corrected for baseline distortions and calibrated using the reference standard TSP. 1H NMR spectra (δ 145 
0.2-10.0) were digitized into consecutive integrated spectral regions (~20,000) of equal width (0.00055 146 
ppm) using MATLAB (Mathworks). The regions containing signals from urea (δ 5.5 – 6.0) and the 147 
residual water (δ 4-7 – 5.2) were removed to minimize baseline effects arising from imperfect water 148 
suppression. Chemical shift variation was minimized across the dataset by applying a recursive 149 
segment-wise peak alignment (RSPA) algorithm to each spectrum. Each spectrum was normalized to 150 
unit area to account for variation in sample concentration. 151 
Quantification of metabolic hormones in plasma 152 
Plasma concentrations of ghrelin, glucagon, glucagon-like peptide (GLP)-1 and leptin were determined 153 
in plasma using the Bio-Plex Pro™ Diabetes Assay (Bio-Rad, Madrid, Spain) according to the 154 
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manufacturer’s instructions. Analysis was carried out with the Bio-Plex® MAGPIX™ Multiplex 155 
Reader and the Bio-Plex Data Pro™ software (BioRad) as in previous studies(25). The limits of 156 
quantification can be found as Supplementary material. 157 
Faecal IgA quantification  158 
The concentration of IgA in faeces was quantified by ELISA following the manufacturer’s instructions 159 
(Bethyl Laboratories, Inc., Montgomery, TX, USA). Absorbance was measured in a microplate 160 
photometer (LabSystems Multiskan) and data were interpolated using ASCENT version 2.6 software 161 
(Thermo Fisher Scientific, Barcelona, Spain) into the standard curves.  162 
Statistical analysis 163 
The number of animals used in each group for detecting a statistically significant difference among 164 
groups assuming that there is not a drop out rate and a Type I error of 0.05 (2-sided) was calculated by 165 
the Appraising Project Office’s program from the Universidad Miguel Hernández de Elche (Alicante) 166 
taking into the account both the metabolic hormones, particularly the leptin and ghrelin concentrations, 167 
and the faecal IgA. Moreover we have adjusted the sample size to the minimum needed following the 168 
University Ethical Committee guidelines and trying to apply the three R’s rule for experimenting in 169 
animals. 170 
 171 
Statistical analysis for body weight, chow intake, faecal IgA and metabolic hormones was performed 172 
using the software package IBM SPSS Statistics 22.0 (SPSS, Inc. USA). Levene’s and Kolmogorov–173 
Smirnov tests were applied to assess variance equality and normal distribution, respectively. 174 
Conventional one-way ANOVA was performed when normal distribution and equality of variance 175 
existed. The Tukey’s test was applied when specific cocoa intake had a significant effect on the 176 
dependent variable. Non-parametric Mann–Whitney U and Wilcoxon tests were used in order to assess 177 
significance for independent and related samples, respectively. Significant differences were established 178 
at P<0.05. 179 
Multivariate modeling was performed in MATLAB using in-house scripts. This included principal 180 
components analysis (PCA) using pareto scaled data and orthogonal projection to latent structures-181 
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discriminant analysis (OPLS-DA) using a unit variance scaling approach. Pairwise OPLS-DA models 182 
were constructed to aid model interpretation and identify discriminatory metabolites between the study 183 
groups. Here, 1H NMR spectroscopic profiles served as the descriptor matrix (X) and the experimental 184 
groups (REF, C10, CF) were used pairwise as the response variable (Y). Orthogonal signal correction 185 
filters were used to remove variation in the descriptor matrix unrelated to the response variable to assist 186 
model interpretation. Loading coefficient plots were generated by back-scaling transformation where 187 
covariance is plotted between the Y-response matrix and the signal intensity of the metabolites in the 188 
NMR data (X). These plots are coloured based on the correlation coefficient (r2) between each 189 
metabolite and the Y-response variable, with red indicating strong significance and blue indicating 190 
weak significance. The predictive performance (Q2Y) of the model was calculated using a seven-fold 191 
cross validation approach and model validity was established by permutation testing 192 
(1000 permutations).  193 
Clustering analysis. Unsupervised hierarchical clustering analysis (HCA) was performed to identify 194 
general patterns of metabonomic variation between samples. To do so, we used the normalized levels 195 
of metabolites identified to contribute to class separation through the OPLS-DA models. For 196 
comparative analysis across different metabolites, data were standardized as z-scores across samples 197 
for each metabolite before clustering, so that the mean is 0 and the standard deviation is 1. This 198 
standardized matrix was subsequently used in unsupervised HCA for samples and metabolites using 199 
Euclidean distance and average linkage, by means of the pdist and linkage functions in the MATLAB 200 
bioinformatics toolbox. Heatmaps and dendrograms following HCA were generated with MATLAB 201 
imagesc and dendrogram functions, respectively. In the heatmaps, a red-blue colour scale is used so 202 
that shades of red and blue represent higher and lower values, respectively, compared with the mean. 203 
Different diet groups are color-coded and shown under the dendrogram for each sample.  204 
Correlation analysis. To explore the functional correlation between the changes on body weight, 205 
metabolism and intestinal immunity, metabonome perturbations and gut microbiome evaluated in a 206 
previous study by Fluorescence in situ hybridization (FISH) coupled to flow cytometry (FC). 207 
Spearman´s correlation analyses were performed on all the samples grouped together. The Benjamini-208 
Hochberg method was used to adjust p-values for multiple testing considering a 5% false discovery rate 209 
(FDR). 210 
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Results 211 
Body weight and food intake 212 
Body weight and food intake were monitored weekly throughout the study (Fig. 1). Initially, no 213 
differences in body weight were observed between groups (mean (g) ± SEM, REF: 43.7±1.1; C10: 214 
45.4±1.4; CF: 44.8±1.1). However, from day 7, a lower body weight gain was observed in C10 animals 215 
compared to the other groups (P<0.05) (Fig. 1(a)). This effect was not related to lower food intake, 216 
which was similar throughout the study among all experimental groups (Fig. 1(b)), being around 15 g 217 
of chow per 100 g of animal the first week of diet and around 12 g after the three weeks of 218 
intervention. No changes in body weight gain were found as a result of CF diet intake. 219 
Fig. 1. Body weight increase (%) compared to the baseline (A) and chow intake (%) compared to the 
REF diet which represents 100% (B) monitored throughout the nutritional intervention. Values are 
expressed as mean ± SEM (n=10). * P<0.05 vs REF diet; and ‡ P<0.05 vs CF diet. 
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 220 
Metabolic hormones  221 
The metabolic hormones quantified in plasma after three-week dietary intervention for all groups are 222 
summarized in Table 1. Both the C10 and CF diets increased the concentration of ghrelin compared to 223 
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the REF group (P<0.05). This increase was higher in the C10 group compared to the CF group 224 
(P<0.05). Both diets also resulted in a lower plasma GLP-1 concentration in comparison with the REF 225 
group (P<0.05). Moreover, the C10 diet reduced the glucagon concentration compared to the REF and 226 
CF diets (P<0.05). The leptin concentration was not affected after the C10 diet but it was up-regulated 227 
as a result of the CF diet intake compared to the rest of the groups (P<0.05) (Table 1). 228 
Table 1. Metabolic hormones in plasma after three weeks of nutritional intervention. Results are 
expressed as mean ± SEM (n=7). * P<0.05 vs REF diet; † P<0.05 vs C10 diet and ‡ P<0.05 vs CF diet. 
 REF C10 CF 
Ghrelin (ng/mL) 30.57 ± 3.9 98.63 ± 18.7*‡ 43.59 ± 4.3* 
GLP-1 (pg/mL) 29.4 ± 16.4 7.4 ± 3.1* 4.2 ± 0.2* 
Glucagon (pg/mL) 180.1 ± 25.3 100.4 ± 3.1*‡ 166.2 ± 26.9 
Leptin (pg/mL) 647.7 ± 135.5 335.4 ± 127.5 968.7 ± 177.6*† 
 
 229 
Faecal IgA 230 
The C10 diet intake resulted in a decrease in the secretory IgA concentration compared to the others 231 
groups (P<0.05) (Fig. 2). The CF diet did not produce any change in the secreted IgA concentration, 232 
which was similar to that quantified in the REF group.  233 
Fig. 2. Faecal IgA concentration determined after three weeks of nutritional intervention. Results are 
expressed as mean ± SEM (n=9-10). * P<0.05 vs REF diet; ‡ P<0.05 vs CF diet. 
Fe
ca
l I
gA
 (n
g/
m
g)
0
10
20
30
40
50
* ‡
REF C10 CF 
 
11 
 
Urinary metabolic profile 234 
An OPLS-DA model with strong predictive ability (Q2Y=0.93; P=0.001) was returned comparing the 235 
metabolic profiles from rats receiving the C10 diet and the REF diet (Fig. 3(a) and 4). Rats fed the C10 236 
diet excreted cocoa-derived metabolites such as N-methylnicotinic acid (NMNA) and nicotine 237 
mononucleotide (NMN), as well as methylxanthine metabolites, i.e. theobromine, xanthine, 1-238 
methylxanthine (1-MX), 3-methylxanthine (3-MX), 7-methylxanthine (7-MX), imidazole, dimethyluric 239 
acid (DMU). In addition, urines from C10 group contained microbial-derived metabolites such as 240 
hippurate and 2-hydroxyisobutyrate (2-HIB), and 4-hydroxypropionic acid (4-HPA), 241 
phenylacetylglutamine (PAG) and indole-3-acetic acid (IAA) that could be derived from the cocoa 242 
polyphenols (epicatechin and procyanidins), aminoacids (tyrosine, phenylalanine, and trypthophan), or 243 
monoamines  (tyramine, tryptamine, and 2-phenylethylamine) contained in cocoa. Moreover, rats 244 
receiving the C10 diet also excreted greater amounts of taurine compared to those receiving the REF 245 
diet. Conversely, animals receiving the C10 diet excreted lower amounts of metabolites related to 246 
energy metabolism (acetone, citrate, 2-oxoglutarate (2-OG), N-methylnicotinamide (NMND)), choline 247 
metabolism (dimethylamine (DMA), dimethylglycine (DMG), choline), and the metabolism of dietary 248 
components (sucrose, glucose, tartrate) compared to those receiving the REF diet. Other metabolites 249 
excreted in lower amounts by the C10 group were those related to endogenous amino acid metabolism 250 
(α-keto-isocaproate (αKIC), α-keto-β-methyl-n-valerate (αKMV), β-hydroxy-β-methylbutyrate (HMB), 251 
3-hydroxyisobutyrate (3-HIB), glycine) and metabolites arising from the gut microbial-host co-252 
metabolism of amino acids (3-indoxyl-sulfate (3-IS), 4-cresyl sulfate (4-CS) and 4-cresyl glucuronide 253 
(4-CG)). Sebacate, 4-guanidinobutanoate, creatinine, allantoin, and pseudouridine were also present in 254 
lower amounts in the urine from C10-fed animals compared to the REF group.  255 
Regarding the CF diet, clear metabolic variation was observed in the urine from rats fed this diet 256 
compared to those fed the REF diet (Fig. 3(b) and 4; OPLS-DA model Q2Y=0.65; P=0.001). Cocoa-257 
derived metabolites such as NMNA, NMN, theobromine, xanthine, 1-MX, 3-MX, 7-MX, and DMU 258 
were found in the urine of rats receiving the CF diet but not those receiving the REF diet. Moreover, 259 
rats following the CF diet excreted higher 2-HIB, IAA, citrate, acetone, NMND, sucrose, glucose, 260 
acetate and tartrate that those following the REF diet, which are related to microbial, energetic or 261 
dietary metabolism. Lower amounts of 4-HPA, hippurate, 3-IS, PAG, αKI, DMG, sebacate, 262 
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4-guanidinobutanoate, ethanol, creatinine, allantoin and pseudouridine were also measured in the 263 
urines of the CF group compared to REF group. 264 
Fig. 3. Orthogonal projection to latent structures-discriminant analysis (OPLS-DA) comparing the urinary metabolic profiles of 
rats receiving different dietary regimens (n=8 for the REF and C10 groups; n=5 for the CF group). Coefficient plots extracted 
from the OPLS-DA models comparing rats receiving REF diet with C10 diet (A); REF diet with CF diet (B); and C10 diet with 
CF diet (C). αKMV,α-keto- β-methyl-n-valerate; αKIC, α-ketoisocaproate; 1-MX,1-methylxanthine; 2-
HIB,2-hydroxyisobutyrate; 2-OG,2-oxoglutarate; 3-HIB,3-hydroxyisobutyrate; 3-IS,3-indoxyl-sulfate; 3-MX,3-
methylxanthine; 4-GB,4-guanidinobutanoic acid; -CS,4-cresyl sulfate; 4-CG,4-cresyl glucuronide; HMB, β-hydroxy-β-
methylbutyrate; 4-HPA,4-hydroxypropionic acid; 7-MX,7-methylxanthine; C10,10% cocoa diet; CF,cocoa fibre diet; 
DMA,dimethylamine; DMG,dimethylglycine; DMU,dimethyluric acid; IAA,indole-3-acetic acid; NAG,N-acetylglycoprotein; 
NMN,nicotine mononucleotide; NMNA,N-methyl-nicotinic acid; NMND,N-methyl-nicotinamide; PAG,phenylacetylglycine; 
REF,Reference diet; TMAO,trimethylamine N-oxide. 
(b)
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Finally, the OPLS-DA model contrasting the urinary metabolic phenotypes from rats receiving the C10 265 
diet and those fed the CF diet (Fig. 3(c) and 4; Q2Y=0.89; P=0.001) also showed some clear 266 
differences. As expected, rats consuming the C10 diet excreted higher levels of cocoa- (NMNA, 267 
NMN), catechin- and methylxanthine- (theobromine, xanthine, 1-MX and 3-MX, imidazole, DMU) 268 
derivatives compared to those fed the CF diet. The C10 diet fed animals also excreted higher amounts 269 
of 4-HPA, hippurate, PAG, IAA and taurine. However, compared to CF group, the C10 diet fed 270 
animals eliminated lower amounts of 3-IS, acetone, citrate, 2-OG, NMND, αKMV, HMB, DMA, 271 
choline, sucrose, glucose, sebacate, 4-guanidinobutanoate, allantoin, pseudouridine and fumarate. 272 
Fig. 4. Dendrogram and heatmap representation of unsupervised hierarchical clustering (HCA) of the metabonome for 
all rats. Each column corresponds to a single rat (n=8 for the REF and C10 groups; n=5 for the CF group), and each 
row corresponds to a specific metabolite. Metabolites identified to contribute to the separation between diets through 
OPLS-DA models were used for sample clustering. Metabolite z-score transformation was performed on the levels of 
each metabolite across samples, with blue denotating a lower and red a higher level compared to the mean. 
Metabolites and samples are clustered using correlation distance and average linkage and colour coded by diet or 
pathway, respectively. HCA grouped the urinary metabolic profiles from the C10-fed animals together and distinct 
from the other studied animals. Profiles from animals receiving the CF diet clustered together and were separated 
from the REF diet. 
Tartrate
REF CF C10
 
14 
 
Correlations between urine metabolites and studied variables  273 
The correlation analysis of the urine metabolic fingerprint with the effects of cocoa on metabolic 274 
hormones (ghrelin, GLP-1, glucagon, leptin), body weight, intestinal immunity (by means of intestinal 275 
IgA levels) and microbiota composition (reported previously(17,26)) was also studied (Fig. 5). Globally, 276 
whereas most of the studied variables were inversely correlated with whole cocoa metabolites, only the 277 
ghrelin concentration was positively correlated with the amount of these metabolites. In fact, the 278 
strongest correlations were found between ghrelin and NMNA, 1-MX, xanthine and theobromine. 279 
Plasma glucagon concentration correlated inversely with these metabolites derived from cocoa, 280 
whereas it has a positive correlation with choline and other metabolites. Body weight was inversely 281 
correlated with cocoa metabolites and a positive correlation with those from the amino acid 282 
metabolism. Similarly, faecal IgA concentration showed an inverse correlation with cocoa-derived 283 
metabolites whereas it was positively correlated with choline metabolites and allantoin. Urinary 284 
metabolites were also correlated with gut microbial groups previously identified to change following 285 
both the C10 and CF intake(17). An inverse correlation was found between the Streptococcus genus and 286 
the excretion of epicatechin (cocoa derived) and 4-HPA (gut microbial metabolism). In addition, a 287 
strong positive correlation was observed between the Firmicutes/Bacteroidetes ratio and choline-288 
related metabolites, whereas it inversely correlated with metabolites derived from cocoa. 289 
 290 
Fig. 5. Correlations between metabolites and responses. The intensity of the colours represents the degree of 
correlation, with red and blue indicating positive and negative correlations, respectively. Metabolites identified to 
contribute to the separation between diets through OPLS-DA models were to obtain the correlations. The order of 
the metabolites is the same obtained in Figure 4, where metabolites have been clustered based on an unsupervised 
hierarchical analysis using a correlation distance and average linkage and colour coded by pathway.  Only 
significant correlations after applying a Benjamini and Hochberg procedure for controlling for a false discovery rate 
of 5% are shown. Correlation coefficients were based on Spearman’s correlation. 
15 
 
 
Other correlations between studied variables 291 
The correlation analysis between the effects of cocoa on the metabolic hormones, body weight, 292 
intestinal immunity and microbiota composition and functionality(17) has been also studied (Fig. 6). 293 
When samples from all the groups were considered together, the body weight correlated positively with 294 
both plasma concentrations of glucagon and leptin, but negatively with plasma ghrelin concentration. 295 
In addition, body weight showed a positive correlation with the faecal IgA content and the 296 
Streptococcus genus proportion, among others. 297 
The metabolic hormones showed significant associations with the microbiota composition and 298 
functionality (Fig. 6). Particularly, the glucagon concentration was positively correlated with the faecal 299 
counts of Bifidobacterium spp., whereas the ghrelin concentration correlated inversely with 300 
Bifidobacterium spp. proportion and the caecal butyric acid concentration. Finally, faecal IgA was 301 
positively associated with the faecal Streptococcus spp. counts and inversely with ghrelin 302 
concentration. 303 
16 
 
Fig. 6. Correlations between body weight, metabolic hormones, intestinal immunity and microbiota 
composition and functionality. The intensity of the colours represents the degree of correlation, with 
red and blue indicating positive and negative correlations, respectively. Only significant correlations 
after applying a Benjamini and Hochberg procedure for controlling for a false discovery rate of 5% are 
shown. Correlation coefficients were based on Spearman’s correlation. 
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 304 
Discussion 305 
We have previously reported that a 10% cocoa diet in rats results in a lower body weight increase, 306 
attenuates intestinal IgA secretion and modifies gut microbiota composition(13,17,26–29). In the present 307 
study, we demonstrate that the cocoa intake alters the metabolic hormones and results in a distinct 308 
urinary metabolic pattern. Moreover, correlations between urinary metabolites and those variables in 309 
which cocoa has an effect (i.e. body weight, metabolic hormones and intestinal immunity) were 310 
established, as well as between these modified variables. In addition, we have also correlated all these 311 
variables with the cocoa effects on microbiota composition and functionality from a previous study(17). 312 
Interestingly, the effects of either whole cocoa or cocoa fibre on the metabolic hormones and urinary 313 
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metabolic profiles were different, which reflects the role of non-fibre cocoa compounds as well as the 314 
interaction between fibre and non-fibre cocoa compounds in these effects. To strengthen this 315 
conclusion, further studies testing the contribution of cocoa polyphenols to the aforementioned effects 316 
related to the urinary metabolic profile and metabolic hormones should be carried out. 317 
As expected, the urinary metabolic profiles of the C10 group animals showed the highest excretion of 318 
cocoa-derived metabolites, which is in line with previous controlled cocoa dietary intervention 319 
studies(30–32). These metabolites include both the flavonoid and methylxanthine derivatives, some of 320 
them produced by the gut microbiota. This reinforces the fact that some of these cocoa compounds 321 
reach the colon intact, where they are metabolized by intestinal bacteria(6,8). However, these metabolites 322 
were found in a lower amount in the urine of animals fed the cocoa fibre, confirming the lower 323 
concentrations of polyphenols and methylxanthines in the fibre powder used in the present study.  324 
Rats fed a C10 diet excreted lower amounts of αKMV and αKIC, both derived from the endogenous 325 
catabolism of the branched-chain amino acids (BCAA). In comparison with the CF diet, the amount of 326 
glucose, sucrose and tricarboxylic acid (TCA) cycle intermediates (citrate, 2-OG, and fumarate) was 327 
lower in the C10 group, indicating that the TCA cycle was down-regulated after the cocoa intake. 328 
These changes, together with the lower urinary excretion of acetone, suggest an alteration to energy 329 
metabolism through the modulation of ketogenesis, BCAA metabolism, and TCA cycle. This shift in 330 
energy strategy, together with the lower expression of genes involved in lipid metabolism(33),  may 331 
contribute to the reduction of body weight in C10-fed rats, reported here and in previous studies(23,26,28). 332 
Changes in NAD+ pathway metabolism further support an alteration in energy metabolism. Thus, 333 
NAD+ is required in TCA cycle and oxidative phosphorylation in the mitochondria to produce 334 
energy(34). It can be synthesized from NMN and nicotinic acid, which were excreted in higher amounts 335 
by C10 rats. On the other hand, the NAD+-consuming enzymes all generate nicotinamide as by-336 
product, which can then be recycled to generate NMN by nicotinamide phophoribosyltranferase 337 
(NAMPT). However, it can also be methylated by nicontiamide N-methyltransferase (NNMT) to 338 
NMND, which was excreted in lower amounts by rats following a C10 diet. Recently, it was suggested 339 
that inhibition of NNMT protected against diet-induced obesity by increasing energy expenditure(35). 340 
Therefore, the lower urinary excretion of NMND could also explain the lower body weight increase 341 
observed in the present study by C10 rats. 342 
18 
 
In addition, increased levels of NMND in urine were correlated with peroxisome proliferators(36), 343 
which participate in the generation of reactive oxygen species (ROS)(37). Changes in NAD+ metabolism 344 
have been associated with oxidative stress in aging and neurodegeneration(34). Hence, the lower 345 
excretion of NMND after the C10 diet may reflect a reduction in oxidative stress. Consistent with this, 346 
rats maintained on a C10 diet excreted lower amounts of pseudouridine, which is the oxidized form of 347 
urinary nucleosides. Elevated levels of pseudouridine have been previously identified as indicators of 348 
liver damage induced by inflammation related to oxidative stress(38). In addition, the gut microbiota 349 
produces potentially toxic substances derived from protein metabolism(39), such as the uremic toxins 4-350 
CS and 3-IS, derived from tyrosine and tryptophan, respectively. Both uremic toxins have shown to 351 
lead to changes in NAD metabolism, by increasing NADPH oxidase activity, and to increase ROS 352 
production(40,41). Hence, the lower urinary excretion of 4-CS, 4-CG, and 3-IS by C10 mice strengthens 353 
the possible reduction in oxidative stress after cocoa consumption. 354 
Microbial cocoa metabolism led to a higher excretion of 4-HPA, IAA, hippurate and PAG in the C10 355 
group compared to both CF and REF groups, which could arise from the differences in cocoa 356 
compounds between the diets. Cocoa is rich in monoamines, such as tyramine, tryptamine and 357 
2-phenylethylamine, which can be degraded by gut bacteria to 4-HPA, IAA, and PAG, respectively. 358 
These three metabolites can also be derived from the aminoacid catabolism of tyrosine, tryptophan, and 359 
phenylalanine by the gut microbiota, respectively. The gut microbiota can also degrade cocoa 360 
polyphenols to quinic acid and benzoic acid, which are then oxidized to hippurate and other phenol-361 
related metabolites such as 4-HPA and PAG. Interestingly, NMND, 3-IS and pseudouridine, were 362 
excreted in lower amounts after the C10 diet compared to the CF diet. This suggests a shift in the 363 
composition and functionality of the gut microbiota towards a more favourable and less oxidative 364 
profile. This further suggests that rather than its fibre content it is the other cocoa compounds that 365 
contribute to the beneficial effects of cocoa. An inverse correlation was observed between cocoa 366 
metabolites and body weight, the highest correlation being with imidazole, one of the smallest 367 
metabolites derived from methylxanthines.This clearly suggests that theobromine, a methylxanthine 368 
present in cocoa in a high concentration, and its metabolites contribute to the effects of cocoa on body 369 
weight. . An inverse association was also found between body weight and the presence of metabolites 370 
derived from microbial metabolism, especially with PAG and 4-HPA. Regardless of other reported 371 
mechanisms(42–44), the contribution of microbiota composition and its activity should be considered in 372 
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the regulatory effect of cocoa on body weight. In fact, it has been shown that intake of the C10 diet 373 
decreased the abundance of the Staphylococcus and Streptococcus genera (from the Firmicutes 374 
phylum) and increased the Bacteroides spp. (Bacteroidetes phylum) reducing the Firmicutes to 375 
Bacteroidetes ratio(17,26). This decreased ratio has been associated with lower body weight(45). 376 
Consistently, an inverse correlation was also found between the counts of Streptococcus spp. and the 377 
excreted amounts of 4-HPA and epicatechin in urine.   378 
The relationship between urinary metabolites and intestinal immunity has been established. While the 379 
CF diet did not affect the IgA content, the C10 diet, in accordance with findings from previous 380 
studies(2,13,27), resulted in a significantly lower faecal IgA concentration. In this sense, inverse 381 
correlations between the faecal IgA concentration and the amounts of cocoa epicatechin and 382 
methylxanthine derivatives and those from microbial metabolism were obtained. Overall, these results 383 
suggest that cocoa metabolism may lead to the formation of bioactive products that interact with the 384 
mechanisms involved in IgA secretion and/or its synthesis. Indeed, not only are the metabolites 385 
generated by the microbiota important but also the composition of the microbiota. Besides urinary 386 
metabolites and faecal IgA, metabolic hormones were determined after cocoa and the CF intakes. In 387 
line with previous studies(25), the GLP-1 and glucagon, peptide hormones involved in the glucose 388 
metabolism, were reduced by the C10 diet, but only the former was also modified after the CF intake. 389 
However, only glucagon concentration correlated inversely with the cocoa metabolites. Regarding 390 
hormones involved in regulating food intake, leptin helps to control the appetite and to maintain a 391 
stable body weight(46), whereas ghrelin stimulates appetite, increases fat body mass deposition and 392 
weight gain and influences glucose and lipid metabolism(47). Although the C10 diet increased ghrelin 393 
concentration without changing leptin levels, it did not lead to changes in food intake. Therefore it is 394 
unlikely that these regulating appetite hormones contribute to cocoa influence on body weight. In fact, 395 
ghrelin concentration was inversely associated with body weight. A two-way relationship between 396 
leptin and ghrelin and the gut microbiota has been suggested(46,48). Leptin stimulates mucin production 397 
in the intestine which could affect the composition of the microbiota(49). It has also been suggested that 398 
the microbiota may modulate these hormones through the physiological regulation of the levels and 399 
type of autoantibodies produced against them(50). In this sense, and in line with previous studies(46),  we 400 
found that the proportions of Bifidobacterium and Streptococcus genera correlated positively with 401 
leptin and negatively with ghrelin. Moreover, it has been described that two of the main SCFA 402 
20 
 
(butyrate and propionate) regulate gut hormone release(51). In this regard, our study demonstrates that 403 
the ghrelin concentration was inversely correlated with the butyric acid concentration in cecum content. 404 
Therefore, although hormone effects on microbiota cannot be discarded, the cocoa modulatory effect 405 
on the microbiota composition and functionality might be partially responsible for the changes 406 
observed in both hormone concentrations.  407 
In summary, through a metabonomic approach, we have described the urinary metabolites derived from 408 
cocoa and cocoa fibre intake that can be used as consumption markers in health conditions. Moreover, 409 
the lower excretion of certain host and microbial metabolites reflected a shift in the host energy and 410 
amino acid metabolism due to cocoa compounds, but not to cocoa fibre diet. Metabolic associations 411 
were identified with body weight, intestinal IgA, the metabolic hormone profile and microbiota 412 
composition extending our understanding of the mechanisms through which cocoa may impact on 413 
healthy. Such effects were not restricted solely to the cocoa fibre and the contribution of other cocoa 414 
compounds has been demonstrated. Further studies should be carried out to evaluate the precise 415 
contribution of cocoa methylxanthines and also to study these associations in the context of weight-416 
altering stimulus  417 
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